We evaluated the reporting quality of RCTs in cardiothoracic surgery. The reporting quality was suboptimal as assessed by standard quality scores and CONSORT guidelines. We discuss the possible reasons for this and how reporting may be improved.
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297 Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer Leah M. Backhus, MD, Eric Sievers, MD, Gloria Y. Lin, MD, Roberto Castanos, Robert D. Bart, MD, Vaughn A. Starnes, MD, and Ross M. Bremner, MD, PhD, Los Angeles, Calif We examined the effects of perioperative COX blockade on circulating tumor cell metastases, CD44 expression, and cancer cell-ECM adhesion in NSCLC. Perioperative and continuous celecoxib treatment reduced tumor metastases. Celecoxib also decreased CD44 expression and inhibited cell-ECM adhesion. Perioperative modulation of COX-2 may minimize metastases during this high-risk period. Thorsten Krueger, MD, Andrea Kuemmerle, PhD, Marek Kosinski, PhD, Alban Denys, MD, Lennard Magnusson, MD, Roger Stupp, MD, Angelika Bischof Delaloye, MD, Walter Klepetko, MD, Laurent Decosterd, PhD, Hans-Beat Ris, MD, and Michael Dusmet, MD, Lausanne, Switzerland, and Vienna, Austria Single-pass cytostatic lung perfusion with doxorubicin resulted in a more heterogeneous spatial regional blood flow and drug distribution during perfusion compared with IV drug administration in a porcine model, irrespective of the mode of perfusion applied. 320 Usefulness and complications of computed tomography-guided lipiodol marking for fluoroscopy-assisted thoracoscopic resection of small pulmonary nodules: Experience with 174 nodules Ken-ichi Watanabe, MD, Hiroaki Nomori, MD, PhD, Takashi Ohtsuka, MD, PhD, Masahiro Kaji, MD, PhD, Tsuguo Naruke, MD, PhD, and Keiichi Suemasu, MD, PhD, Tokyo and Kumamoto, Japan Computed tomography-guided lipiodol marking was performed on 174 nodules. Lipiodol marking is a useful, safe, and inexpensive procedure for localizing ground-glass opacity lesions, small pulmonary nodules, or both for thoracoscopic resection. We conducted a large animal study to examine the effects of 3 commercially available surgical adhesives. Among the tissue adhesives used in this study, GRF appeared to be superior to CYAC and AG glue. AG, however, caused severe adverse histologic effects and cannot be recommended for bonding coronary anastomoses.
Results of endovascular repair of the thoracic aorta with the Talent Thoracic stent graft: The Talent Thoracic Retrospective Registry
Rossella Fattori, MD, Christoph A. Nienaber, MD, Hervé Rousseau, MD, Jean-Paul Beregi, MD, Robin Heijmen, MD, Martin Grabenwöger, MD, Philippe Piquet, MD, Luigi Lovato, MD, Chaouki Dabbech, MD, Stephan Kische, MD, Virginia Gaxotte, MD, Marc Schepens, MD, Marek Ehrlich, MD, and Jean-Michelle Bartoli, MD, Bologna, Italy, Rostock, Germany, Toulouse, Lille, and Marseille, France, Nieuwegein, The Netherlands, and Vienna, Austria The TTR was designed to evaluate the impact of endovascular therapy on 457 patients treated for thoracic aortic diseases in 7 major European referral centers over an 8-year period. KaplanMeier overall survival estimate at 1 year was 90.97%, at 3 years was 85.36%, and at 5 years was 77.49%. At the same intervals, freedom from a second procedure (either open conversion or endovascular) was 92.45%, 81.3%, and 70.0%, respectively. Endovascular treatment for thoracic aortic disease with the Talent stent graft is associated with low early morbidity and mortality rates also for patients who are at high risk and treated on an emergency basis.
340 Evaluation of a novel device for left atrial appendage exclusion: The secondgeneration atrial exclusion device Keiji Kamohara, MD, Kiyotaka Fukamachi, MD, PhD, Yoshio Ootaki, MD, PhD, Masatoshi Akiyama, MD, PhD, Faruk Cingoz, MD, Chiyo Ootaki, MD, D. Geoffrey Vince, PhD, Zoran B. Popović, MD, Michael W. Kopcak, Jr, BA, Raymond Dessoffy, AA, Jenny Liu, BA, and A. Marc Gillinov, MD, Cleveland, Ohio The second-generation left atrial exclusion device enabled rapid, reliable, and safe epicardial LAA exclusion in a canine model. Clinical application may provide a new therapeutic option for reducing the risk of stroke in patients with AF.
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347 Long-term results of aortic valve-sparing operations for aortic root aneurysm Tirone E. David, MD, Christopher M. Feindel, MD, Gary D. Webb, MD, Jack M. Colman, MD, Susan Armstrong, MSc, and Manjula Maganti, MSc, Toronto, Ontario, Canada The longitudinal outcomes of 220 patients who had aortic valve-sparing operations for aortic root aneurysm revealed a 10-year survival only slightly lower than that of the general population, a freedom from moderate or severe aortic insufficiency of 85% Ϯ 5%, and a freedom from aortic valve replacement of 95% Ϯ 3%. 
